Xinlang Port Stock NewsFuhong Hanlin-B(02696) the current price rose 10.44% to 57.1 yuan, with an intraday high of 57.25 yuan; about 520000 shares were traded, involving an investment of 28.81 million yuan.

Fuhong Hanlin announced a few days ago that Shanghai Fuhong Hanlin Biopharmaceuticals, a wholly-owned subsidiary, has completed the record of adding key equipment for the production license to the Shanghai Drug Administration for four new 2000L bioreactors at the production base in Xuhui District, Shanghai.

At presentHang Seng IndexIt was down 497 points or 1.90% at 25712 points, with a turnover of 124.627 billion yuan on the main board. The index of state-owned enterprises was at 10533 points, down 248points or 2.30%.

Shanghai Composite IndexIt closed at 3410 points, down 40 points or 1.17%, with a turnover of 490.692 billion yuan.

The Shenzhen Composite component index was at 13766 points, up 11:00 or 0.08%, with a turnover of 636.805 billion yuan.

The performance of the same plate or related shares is listed in the table:

Change in current price of shares (serial number)

-

Fuhong Hanlin (02696) 57.10 yuan up 10.44%

Kingsley (01548) 15.90 yuan down 0.13%

Golly Pharmaceuticals (01672) 3.24 yuan down 0.61%

INNOVENT BIO(01801) 58.80 yuan down 4.55%

Dongyao Pharmaceutical (01875) 4.91 yuan up 0.41%

Junshi Bio (01877) 59.00 yuan up 4.33%

Wuxi Biologics(02269) 146.30 yuan up 2.31%

Hua Medicine (02552) 7.42 yuan down 1.2%

Cornerstone Pharmaceutical (02616) 10.96 yuan down 1.79%

CANSINOBIO (06185) 225.40 yuan fell by 0.62%

-